open access

Vol 13, No 4 (2016)
Research paper
Get Citation

Influence of the methadone maintenance treatment on social and health condition in opioid-dependent individuals

Sylwia Fudalej, Marcin Wojnar
Psychiatria 2016;13(4):219-223.

open access

Vol 13, No 4 (2016)
Prospective study

Abstract

INTRODUCTION: Methadone maintenance treatment (MMT) is considered the most effective approach for opioid dependence. It improves social and health condition, especially in the first period of the treatment. The aim of the present study was to evaluate the influence of the MMT on the quality of life of opioid-dependent individuals in subsequent treatment periods.

MATERIAL AND METHODS: During the phase I of this longitudinal study, 240 patients treated in MMT were included. The average time of the MMT at baseline was one and a half years. The participants were re-interviewed at 6-month follow up. Self-reported questionnaire and standardized measures were used to compare social and clinical characteristics observed in the first and second stage of the study.

RESULTS: At the 6-month follow up, increased employment rates (p = 0.008) and decreased criminality (p < 0.0001) were observed. The prevalence of depressive symptoms (p < 0.0001) and sleep problems (p = 0.021) declined significantly during the follow-up period. High rate of alcohol relapse was noted (46%). The majority of the participants were satisfied with their treatment (70.6%).

CONCLUSIONS: MMT is associated with improved quality of life of the opioid–dependent individuals not only in the first, but also in the subsequent periods of the therapy.

Abstract

INTRODUCTION: Methadone maintenance treatment (MMT) is considered the most effective approach for opioid dependence. It improves social and health condition, especially in the first period of the treatment. The aim of the present study was to evaluate the influence of the MMT on the quality of life of opioid-dependent individuals in subsequent treatment periods.

MATERIAL AND METHODS: During the phase I of this longitudinal study, 240 patients treated in MMT were included. The average time of the MMT at baseline was one and a half years. The participants were re-interviewed at 6-month follow up. Self-reported questionnaire and standardized measures were used to compare social and clinical characteristics observed in the first and second stage of the study.

RESULTS: At the 6-month follow up, increased employment rates (p = 0.008) and decreased criminality (p < 0.0001) were observed. The prevalence of depressive symptoms (p < 0.0001) and sleep problems (p = 0.021) declined significantly during the follow-up period. High rate of alcohol relapse was noted (46%). The majority of the participants were satisfied with their treatment (70.6%).

CONCLUSIONS: MMT is associated with improved quality of life of the opioid–dependent individuals not only in the first, but also in the subsequent periods of the therapy.

Get Citation

Keywords

opioid dependence, methadone maintenance treatment, social functioning, health condition

About this article
Title

Influence of the methadone maintenance treatment on social and health condition in opioid-dependent individuals

Journal

Psychiatria (Psychiatry)

Issue

Vol 13, No 4 (2016)

Article type

Research paper

Pages

219-223

Bibliographic record

Psychiatria 2016;13(4):219-223.

Keywords

opioid dependence
methadone maintenance treatment
social functioning
health condition

Authors

Sylwia Fudalej
Marcin Wojnar

References (17)
  1. Mounteney J, Griffiths P, Sedefov R, et al. The drug situation in Europe: an overview of data available on illicit drugs and new psychoactive substances from European monitoring in 2015. Addiction. 2016; 111(1): 34–48.
  2. Jung WI, Lee YB, Kim DK, et al. A Cost Estimation Development Methodology via CER's Linear Combination. IE interfaces. 2012; 25(3): 347–356.
  3. Ayanga D, Shorter D, Kosten TR. Update on pharmacotherapy for treatment of opioid use disorder. Expert Opin Pharmacother. 2016; 17(17): 2307–2318.
  4. De Maeyer J, Vanderplasschen W, Broekaert E. Quality of life among opiate-dependent individuals: A review of the literature. Int J Drug Policy. 2010; 21(5): 364–380.
  5. Weissman MM, Slobetz F, Prusoff B, et al. Clinical depression among narcotic addicts maintained on methadone in the community. Am J Psychiatry. 1976; 133(12): 1434–1438.
  6. WHO: International classification of diseases and related health problems (ICD-10). http://apps.who.int/classifications/ icd10/browse/2014/en (5.05.2016).
  7. Wittkampf KA, Naeije L, Schene AH, et al. Diagnostic accuracy of the mood module of the Patient Health Questionnaire: a systematic review. Gen Hosp Psychiatry. 2007; 29(5): 388–395.
  8. Douglass AB, Bornstein R, Nino-Murcia G, et al. The Sleep Disorders Questionnaire. I: Creation and multivariate structure of SDQ. Sleep. 1994; 17(2): 160–167.
  9. Sherbourne CD, Stewart AL. The MOS social support survey. Soc Sci Med. 1991; 32(6): 705–714.
  10. Darke S, Ross J, Teesson M, et al. Factors associated with 12 months continuous heroin abstinence: findings from the Australian Treatment Outcome Study (ATOS). J Subst Abuse Treat. 2005; 28(3): 255–263.
  11. Schwartz RP, Kelly SM, Gryczynski J, et al. Heroin Use, HIV-Risk, and Criminal Behavior in Baltimore: Findings from Clinical Research. J Addict Dis. 2015; 34(2-3): 151–161.
  12. Zhou K, Li H, Wei X, et al. Relationships between perceived social support and retention among patients in methadone maintenance treatment in mainland China. Psychol Health Med. 2017; 22(4): 493–500.
  13. Havard A, Teesson M, Darke S, et al. Depression among heroin users: 12-Month outcomes from the Australian Treatment Outcome Study (ATOS). J Subst Abuse Treat. 2006; 30(4): 355–362.
  14. Dean AJ, Bell J, Christie MJ, et al. Depressive symptoms during buprenorphine vs. methadone maintenance: findings from a randomised, controlled trial in opioid dependence. Eur Psychiatry. 2004; 19(8): 510–513.
  15. Medrano MA, Hatch JP, Zule WA, et al. Psychological distress in childhood trauma survivors who abuse drugs. Am J Drug Alcohol Abuse. 2002; 28(1): 1–13.
  16. Dube SR, Anda RF, Felitti VJ, et al. Exposure to abuse, neglect, and household dysfunction among adults who witnessed intimate partner violence as children: implications for health and social services. Violence Vict. 2002; 17(1): 3–17.
  17. Kuba A, Wawrzyniak Z, Zalewska-Kaszubska J. Metadonowa terapia substytucyjna w opinii pacjentów programu metadonowego z województwa łódzkiego – skuteczność, korzyści, problemy. Alcoholism and Drug Addiction. 2014; 27(1): 55–65.

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Wydawcą serwisu jest Via Medica sp. z o.o. sp. komandytowa, ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl